Every investor wants to maximize their returns, and investing in biotech has historically been a good bet for risk-tolerant investors. 2017 saw a record amount of venture capital (VC) funding in biotech, with about $9.3 billion dollars invested. Of note, Atlas Venture (Cambridge, MA) established a new $350 million fund, Fund XI, for investing in…